Are the new clinical trial transparency rules incompatible with the patentability requirements in Europe?
Crossref DOI link: https://doi.org/10.1038/nbt.4265
Published Online: 2018-10-01
Published Print: 2018-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kallenbach, Lorenz
Vallazza, Marco K
Text and Data Mining valid from 2018-10-01
Article History
First Online: 1 October 2018
Competing interests
: The authors declare no competing financial interests.